Search company, investor...

Meditrina Hospitals


Unattributed VC | Alive

Total Raised


Last Raised

$6M | 9 yrs ago

About Meditrina Hospitals

Meditrina Hospitals operates three specialty in hospitals (SIH) centers and one multi-specialty hospital in south and central Kerala.

Headquarters Location

TC 2 / 2367-1, Pattom Vrindavan Gardens, Pottakkuzhi, Thiruvananthapuram

Kerala, 695 004,


+91 471 306 3000

Missing: Meditrina Hospitals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Meditrina Hospitals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Meditrina Hospitals News

Dr. N. Prathap Kumar Successfully Performs Zero Contrast Angioplasty in Chronic Kidney Disease Patients

Apr 15, 2021

New On News India’s renowned Interventional Cardiologist and Chairman, Meditrina Group of Hospitals, Dr. N. Prathap Kumar is known for his zeal and passion for innovation & research in medical sciences. At the helm of Kerala headquartered Meditrina Hospitals, Dr. N. Prathap Kumar is pleased to announce his feat of over 40 zero contrast angioplasties in various Meditrina Hospitals across the country in last few months. Dr. N. Prathap Kumar, Chief Interventional Cardiologist, Meditrina Hospitals Intravascular administration of iodinated contrast media is common but for patients that suffer from acute kidney deficits, contrast dye is associated with numerous adverse outcomes. Dr. N. Prathap Kumar who is internationally acclaimed for performing most complex angioplasties has been working on ‘zero contrast‘ technique and has demonstrated 100% success rate in over 40 such angioplasties. Dr. N. Prathap Kumar says, “Though the incidence of Contrast-Induced Nephropathy in patients with normal renal function is low, it increases significantly among patients with chronic kidney disease and diabetes. The zero contrast technique adopted by us has shown promising results. We have performed this technique multiple times in the last few months in our hospitals and not even a single patient had to face chances of permanent dialysis.” Angiography is performed in heart patients to identify the blockage in the heart and to understand the anatomy of the blood vessels of the heart. This helps the doctors to choose between balloon angioplasty or bypass surgery as the treatment solution. Prior to Angiography, normally patients are administered iodine contrast liquid from 25 ml to 100 ml depending on the case requirement, which may be risky sometimes for patients who already have underlying kidney problems. When the contrast is restricted to a bare minimum amount, the kidneys chances of getting impacted are greatly reduced. This is especially true in a patient with high creatinine level and old age patients with low haemoglobin level. When angiogram is done in patients with the above-mentioned conditions, with high contrast or a large amount of dye that gets into the body for the procedure, patients may go into kidney failure, pushing them into a condition of permanent dialysis. This complication happens in at least 5-20% of such cases. “We have data of patients who have undergone the Zero Contrast angiography in most complex cases including patients with calcium, in tortuous anatomy and instances of 100 blocked vessel and all cases are doing fine. With the help IVUS imaging, multiple stents have also been planted in patients,” adds Dr. N. Prathap Kumar. Depending on the kidney function, one can categorise the kidney patient into three spectrums – patient with normal kidney function, patient with abnormal kidney function but has not undergone dialysis, patient with abnormal kidney function and is on dialysis. In the 1st & 3rd category, there is not much concern about contrast amount as their chances of getting further into dialysis are less than 0.3 percent. But in the 2nd category of patients with impaired kidney function who are undergoing angioplasty, the chances of permanent dialysis increases significantly. To conclude Dr. Kumar says “It is technically very promising approach for the prevention of contrast-induced nephropathy (CIN). Zero contrast is creating a new era in the field of coronary intervention especially treating those patients with chronic issues including diabetes, heart failure, acute coronary syndrome and cardiogenic shock, for such patients zero contrast technique is a boon and brings in new hope.”

Meditrina Hospitals Frequently Asked Questions (FAQ)

  • Where is Meditrina Hospitals's headquarters?

    Meditrina Hospitals's headquarters is located at TC 2 / 2367-1, Pattom, Kerala.

  • What is Meditrina Hospitals's latest funding round?

    Meditrina Hospitals's latest funding round is Unattributed VC.

  • How much did Meditrina Hospitals raise?

    Meditrina Hospitals raised a total of $6M.

  • Who are the investors of Meditrina Hospitals?

    Investors of Meditrina Hospitals include Matrix Partners India.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.